We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Laurie B Riccio has been assisting clients through the H1B Visa process since 2020.

As of 2022, Laurie B Riccio has succesfully submitted and recieved certification for 486 cases.

Laurie B Riccio is located in Boston, MA, and has represented 100 employers for the H1B Visa Process

609
Cases Handled
486
Cases Certified
79.80%
Approval

Cases Handled by Laurie B Riccio

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-21168-408323 Certified Physicists Other Scientific And Technical Consulting Services 1366 Technologies Inc 2021
I-200-22032-868755 Certified Medical Scientists Except Epidemiologists Psychiatric And Substance Abuse Hospitals Mclean Hospital 2022
I-200-22250-458319 Certified Medical Scientists Except Epidemiologists General Medical And Surgical Hospitals General Hospital Corp 2022
I-200-22230-425258 Certified Medical Scientists Except Epidemiologists General Medical And Surgical Hospitals General Hospital Corp 2022
I-200-20343-941416 Certified - Withdrawn Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools New England College Of Optometry 2022
I-200-20343-941414 Certified - Withdrawn Medical Scientists Except Epidemiologists Colleges Universities And Professional Schools New England College Of Optometry 2022
I-200-20007-236555 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Arqule Inc 2020
I-200-22111-093220 Certified Medical Scientists Except Epidemiologists Pharmaceutical Preparation Manufacturing Tcr2 Therapeutics Inc 2022
I-200-22104-070814 Certified Medical Scientists Except Epidemiologists Pharmaceutical Preparation Manufacturing Tcr2 Therapeutics Inc 2022
I-200-22068-963520 Certified Medical Scientists Except Epidemiologists Pharmaceutical Preparation Manufacturing Tcr2 Therapeutics Inc 2022